Do Statins Reduce Atrial Fibrillation After Coronary Artery Bypass Grafting?

Area of Science:

• Cardiology
• Cardiac Surgery
• Pharmacology

Background:

• Atrial Fibrillation (AF) is a frequent complication following coronary artery bypass grafting (CABG).
• Existing research on the prophylactic effect of preoperative statins against postoperative AF is conflicting.
• This study investigates the efficacy of preoperative statin therapy in preventing AF after CABG.

Purpose of the Study:

• To determine if preoperative statin administration reduces the incidence of postoperative atrial fibrillation.
• To analyze the impact of preoperative statins on other major adverse cardiac events and hospital stay duration.

Main Methods:

• Retrospective cohort study utilizing propensity score-matching.
• Analysis included 427 matched pairs of patients undergoing CABG.
• Primary endpoint: incidence of postoperative AF. Secondary endpoints: 30-day mortality, stroke, myocardial infarction, and length of hospital stay.

Main Results:

• No significant difference in postoperative AF incidence between statin users (28.1%) and non-users (29.7%; p=0.764).
• No significant differences observed in 30-day mortality, stroke, myocardial infarction, or length of hospital stay between the groups.
• Statistical analysis confirmed no protective effect of preoperative statins on AF development.

Conclusions:

• Preoperative statin therapy did not demonstrate a protective effect against postoperative atrial fibrillation in this propensity-matched cohort.
• The findings suggest that routine use of preoperative statins may not be beneficial for preventing AF after CABG.
• Further research may be needed to explore alternative strategies for AF prevention in cardiac surgery patients.